Current Medicinal Chemistry

This journal supports open access

Editor-in-Chief:

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK

Back

Become EABM
Become Reviewer

Irreversible Protein Kinase Inhibitors

Volume:18   Issue:20
Pp: 2981-2994
L. Garuti, M. Roberti and G. Bottegoni
DOI: 10.2174/092986711796391705

ATP-Competitive Inhibitors of mTOR: An Update

Volume:18   Issue:20
Pp: 2995-3014
S. Schenone, C. Brullo, F. Musumeci, M. Radi and M. Botta
DOI: 10.2174/092986711796391651

Targeting the Human DEAD-Box Polypeptide 3 (DDX3) RNA Helicase as a Novel Strategy to Inhibit Viral Replication

Volume:18   Issue:20
Pp: 3015-3027
A. Garbelli, M. Radi, F. Falchi, S. Beermann, S. Zanoli, F. Manetti, U. Dietrich, M. Botta and G. Maga
DOI: 10.2174/092986711796391688

Biological Potential and Structure-Activity Relationships of Most Recently Developed Vascular Disrupting Agents: An Overview of New Derivatives of Natural Combretastatin A-4

Volume:18   Issue:20
Pp: 3035-3081
M. Marrelli, F. Conforti, G. A. Statti, X. Cachet, S. Michel, F. Tillequin and F. Menichini
DOI: 10.2174/092986711796391642

Current Progress in Antifibroitcs

Volume:18   Issue:20
Pp: 3082-3092
S. A.A. El Bialy, K. F. Abd El Kader and M. B. El-Ashmawy
DOI: 10.2174/092986711796391679

Bone Metastatic Disease: Taking Aim at New Therapeutic Targets

Volume:18   Issue:20
Pp: 3093-3115
F. Coluzzi, E. Di Bussolo, I. Mandatori and C. Mattia
DOI: 10.2174/092986711796391660